Szerző: " Herbst Roy S."

Wu Yi-Long; Tsuboi Masahiro; He Jie; John Thomas; Grohe Christian; Majem Margarita; Goldman Jonathan W.; Laktionov Konstantin; Kim Sang-We; Kato Terufumi; Vu Huu-Vinh; Lu Shun; Lee Kye-Young; Akewanlop Charuwan; Yu Chong-Jen; de Marinis Filippo; Bonanno Laura; Domine Manuel; Shepherd Frances A.; Zeng Lingmin; Hodge Rachel; Atasoy Ajlan; Rukazenkov Yuri; Herbst Roy S.; Kollaborációs szervezet: ADAURA Investigators; Somfay Attila; et al. (kollab. közrem.): Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer.
NEW ENGLAND JOURNAL OF MEDICINE, 383 (18). pp. 1711-1723. ISSN 0028-4793 (2020)

Heymach John V.; Johnson Bruce E.; Prager Diane; Csada Edit; Roubec Jaromír; Pešek Miloš; Špásová Irena; Belani Chandra P.; Bodrogi István; Gadgeel Shirish; Kennedy Sarah J.; Hou Jennie; Herbst Roy S.: Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancer.
JOURNAL OF CLINICAL ONCOLOGY, 25 (27). pp. 4270-4277. ISSN 0732-183X (2007)